Osteoprotegerin, IL-6, IL-1, TNF-α and TGF-β concentrations during acetate-free biofiltration

被引:0
作者
Buemi, M
Floccari, F
Crisafulli, A
Cavallaro, E
Ruello, A
Caccamo, C
Loddo, S
Aloisi, C
Corica, F
Romeo, A
Frisina, N
Teti, D
机构
[1] Univ Messina, Dept Internal Med, Unita Terapia Subintens Metab & Dialitica, Messina, Italy
[2] Univ Messina, Clin Pathol Inst, Messina, Italy
关键词
osteoprotegerin; interleukin-I; interleukin-6; tumor necrosis factor alpha; transforming growth factor beta; acetate-free biofiltration; uremic osteodystrophy;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To ascertain the effect of acetate-free biofiltration (AFB), performed with polyacrilonitrile filters, on serum concentrations of osteoprotegerin (OPG) and other bone-acting cytokines (interleukin (IL) IL-1, IL-6, tumor necrosis factor alpha (TNF-alpha) and transforming growth factor beta (TGF-beta)) in end-stage renal disease (ESRD) patients, we evaluated these parameters during an AFB session and 24 hr after it ended. In second time we verified the existence of eventual correlations among serum levels of all these cytokines at different times. We investigated 48 subjects: 24 healthy volunteers (controls) (12 females, 12 males, mean age 55 +/- 9 yrs) and 24 ESRD patients (12 females, 12 males, mean age 58 +/- 6.7 yrs, mean dialytic age 2.7 +/- 1.6 yrs, residual glomerular filtration rate (GFR) 2.3 +/- 0.6 ml/min). All dialyzed patients received regular AFB with polyacrilonitrile filters for 4 hr thrice-weekly. Statistical analysis showed significant increase in basal serum OPG, IL-6 and TNF-alpha concentrations in dialyzed patients compared to controls, while it did not show significant variations for the other cytokines. During the dialytic session, OPG and TGF-beta concentrations did not show significant variations, while serum TNF-alpha, IL-6 and IL-1 levels significantly decreased from the 1st hour of AFB. None of the cytokines showed significant differences between basal and interdialytic values. We did not find correlations between OPG, IL-1, IL-6, TNF-alpha and TGF-beta concentrations during hemodialytic sessions and during the interdialytic interval. It is our opinion that the lack of correlation between serum concentrations, observed in our study, could not exclude the presence of local interferences between OPG and the other cytokines.
引用
收藏
页码:148 / 153
页数:6
相关论文
共 18 条
  • [1] Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes
    Bouman, CSC
    van Olden, RW
    Stoutenbeek, CP
    [J]. BLOOD PURIFICATION, 1998, 16 (05) : 261 - 268
  • [2] CAGLER K, 2000, KIDNEY INT, V62, P1408
  • [3] CARROZZI S, 1992, ASIAO J, V38, P52
  • [4] Serum osteoprotegerin and renal osteodystrophy
    Coen, G
    Ballanti, P
    Balducci, A
    Calabria, S
    Fischer, MS
    Jankovic, L
    Manni, M
    Morosetti, M
    Moscaritolo, E
    Sardella, D
    Bonucci, E
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (02) : 233 - 238
  • [5] Effect of type of dialysis membrane on bone in haemodialysis patients
    Ferreira, A
    Ghazali, A
    Galvao, J
    Souberbielle, JC
    Jehle, PM
    Mohan, S
    Descamps-Latscha, B
    Oprisiu, R
    Fournier, A
    Drüeke, TB
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (06) : 1230 - 1238
  • [6] GOLDFARB S, 1994, J AM SOC NEPHROL, V5, P228
  • [7] Chronic effects of long-term acetate-free biofiltration on the production of interleukin-1 beta and interleukin-1 receptor antagonist by peripheral blood mononuclear cells
    Higuchi, T
    Kuno, T
    Takahashi, S
    Kanmatsuse, K
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1997, 17 (05) : 428 - 434
  • [8] Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines
    Hofbauer, LC
    Dunstan, CR
    Spelsberg, TC
    Riggs, BL
    Khosla, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (03) : 776 - 781
  • [9] Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure
    Kazama, JJ
    Shigematsu, T
    Yano, K
    Tsuda, E
    Miura, M
    Iwasaki, Y
    Kawaguchi, Y
    Gejyo, F
    Kurokawa, K
    Fukagawa, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (03) : 525 - 532
  • [10] Circulating osteoprotegerin is not removed through haemodialysis membrane
    Kazama, JJ
    Kato, H
    Sato, T
    Shigematsu, T
    Fukagawa, M
    Iwasaki, Y
    Gejyo, F
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (10) : 1860 - 1861